As advised via Pharmac Tender announcement there is to be a change in the listing and future sole supply.

New listing from 1 March 2018 HML only.

Pip Taz Sandoz Inj 4 g with tazobactam 0.5 g 10 vials.                          Pharmacode  2539187                     Schedule price $38.00

Incumbent brand(s)

Piperacillin with tazobactam  Inj 4 g with tazobactam 0.5 g, vial, single vial Pharmacode  2294850             Schedule price $5.40 (delisting 1 January 2018)

Tazocin In j 4 g with tazobactam 0.5 g, vial, single vial                          Pharmacode 2270021            Schedule price $15.50 (delisting 1 May 2018)

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

It is our current intention to exit the incumbent brand(s) by the date of listing of the new brand, pending product availability.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author